Semax Where to Buy: What the Certificate Has to Cover
Summary: A buying framework for a Russian nootropic peptide that has no approved medical route in the West, applied line by line to the one certificate in this market that runs the tests FDA cares about.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
Semax where to buy is a documents question long before it is a price question, and the first thing this site owes you is that Semax is not a GLP-1 and has nothing to do with weight loss.
The listing this page keeps checking its own criteria against sits below, so you can open the certificate in another tab and follow along.
Where readers actually buy it
Ascension Peptides — Semax
Research-grade Semax, tested by two outside labs and shipped from the US. The code below takes half off the vial.
The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.
- Batch certificates from two independent labs
- Free shipping over $250
- Ships same day if ordered before 2pm CST
Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 21, 2026.
What is actually in the vial
Most readers here are on semaglutide or tirzepatide, or working out whether to be. Semax turns up in the same forums, usually described as a focus or motivation compound, and it belongs to a completely different category from anything else this site covers.
Semax is a synthetic heptapeptide: seven amino acids, in the order Met-Glu-His-Phe-Pro-Gly-Pro [3]. The first four residues are the ACTH(4-7) fragment, a short piece of adrenocorticotropic hormone, and the Pro-Gly-Pro tail on the end is a stability modification that slows the enzymes which would otherwise break the chain apart quickly. PubChem registers it under the name "ACTH (4-7), Pro-Gly-Pro-", with molecular formula C37H51N9O10S and a molecular weight of 813.9 [3]. It was developed in Russia and carries a Russian registration. It has no FDA approval, for any indication, anywhere in the United States.
It is not an incretin. It does not touch the GLP-1 receptor, does not slow gastric emptying, and has no weight-management indication in any jurisdiction. If someone has sold it to you as a companion to your GLP-1, that pairing is a marketing idea rather than a pharmacological one.
The evidence gap is the part worth sitting with rather than skimming. The medications this site normally covers arrived through large randomized trials with pre-registered endpoints and published results that anyone can read. Semax did not arrive that way. Its clinical record is largely Russian-language and largely not replicated to Western standards, and the second-hand versions circulating in English are routinely quoted at a confidence the underlying work does not support. Report the registration, by all means. Do not adopt the claim.
The regulatory position, stated accurately
Search this compound and you will quickly meet pages saying Semax is "FDA Category 2" or "banned from compounding". Both are wrong, and the correct version is more interesting than the wrong one.
FDA sorts bulk drug substances nominated for compounding under section 503A into three categories. Semax appears in none of them. Search the current category lists, updated May 14, 2026, and the word is simply absent [2].
Where it does appear is on a separate FDA page, in a table headed "Bulk drug substances nominated but withdrawn", which FDA introduces as substances "previously in category 2 of the interim policies" that "were withdrawn by the nominators" [1]. So the pages saying Category 2 are quoting a snapshot that has since moved rather than inventing something. The accurate sentence today is that Semax was nominated, was placed in category 2 while FDA evaluated it under the interim policies, and the nomination was then withdrawn by the nominator. It now sits on no category list at all.
Current 503A category 2 contains exactly six substances: cesium chloride, domperidone, germanium sesquioxide, ibutamoren mesylate, kisspeptin-10, and quinacrine hydrochloride for intrauterine administration [1]. Semax is not one of them.
None of that is approval, and none of it is a safety finding in either direction. It means the question was asked and then dropped before it was answered.
The sentence from FDA that should shape what you buy
The withdrawn-nominations page still records what FDA thought the risk was, and the wording is specific rather than boilerplate:
Read that as a buyer rather than as a regulator. Immunogenicity means your immune system reacting to the material. The two causes FDA names are aggregation, where peptide molecules clump into larger structures the body reads as foreign, and peptide-related impurities, meaning the truncated and modified versions of the sequence that synthesis inevitably leaves behind. Both are manufacturing and handling problems. Both are measurable on paper.
That is what converts a vague worry into a shopping list. A purity figure tells you how much of the powder is the intended sequence. An identity test tells you it is the right sequence at all. An endotoxin result tells you about pyrogen load, which purity testing cannot see, because bacterial endotoxins are cell wall fragments that survive ordinary sterilisation and need their own assay [5]. Those are three separate questions, and most of this market answers only the first two.
Semax where to buy: what each criterion actually rules out
The order below is deliberate. A supplier can be excellent on the bottom rows and still be the wrong purchase if it fails the top ones.
| Criterion | What its absence lets through | How you check before paying |
|---|---|---|
| Batch-specific certificate with the lot printed | Site-wide paperwork describing material you will never receive | The lot on the PDF has to match the listing, then the vial when it lands |
| Purity against a stated specification | A bare percentage with nothing to fail against | Look for the requirement printed next to the result, not just the number |
| Identity by mass spectrometry | A cheaper or truncated sequence sold under the right name | An LC-MS or MS identity line naming the compound tested |
| Bacterial endotoxin result in EU/mL | Pyrogen load, which a purity assay cannot detect | A named method, a numeric result and an acceptance limit, all three |
| Microbial or sterility screen | Contamination in powder that will later be put into solution | A no-growth result with the incubation period and temperature stated |
| Elemental impurities panel | Catalyst and process metals left behind by synthesis | An ICP-MS table with a per-element limit beside each result |
| A named, locatable laboratory | Self-issued paperwork, which verifies nothing at all | A lab name, a report number, and some route to confirm the report exists |
| Domestic stock and a written refund policy | Customs risk, and recourse that lives only in a support inbox | Published terms on the site, and a first tracking scan inside your own country |
| No human-use claims anywhere on the listing | A seller who has misunderstood its own legal position | Read the product page and the footer before you read the price |
None of this needs a chemistry background. All of it needs you to open a PDF instead of reading a landing page, which is exactly the step almost nobody takes.
Running the list against the source this page links
We link Ascension Peptides and earn a commission if you buy through the card above. That is disclosed there and in our disclaimer, and it is the reason to run the checklist strictly rather than gently.
The product is Semax 10 mg, lyophilised powder, listed at $59.99. The code PEPTIDEDECK takes it to $30.00, which is $3.00 per milligram. Buying 3, 5 or 10 vials takes 3%, 5% or 10% off the list price as a separate mechanism, and free shipping starts at $250. Stock is domestic and the listing is labelled for laboratory research only.
On the documentation rows, open the certificate rather than taking this page's word for it [4]. It is a four-part document issued by Kovera Labs on batch 30-05260628, report number KVR-2026-E848E0, certified 15 June 2026, and it is substantially more complete than this market usually publishes:
- Purity 99.886% by RP-HPLC on a C18 column with diode array detection at 214 nm, against a stated specification of greater than 98%. The specification is printed beside the result, which is the part that matters.
- Identity confirmed by LC-MS, and the sample information block lists the molecular formula C37H51N9O10S and CAS number 80714-61-0, both of which match the public record [3].
- Bacterial endotoxin by kinetic chromogenic LAL to USP Chapter 85, analysed 29 May 2026, reported below 0.20 EU/mL against an acceptance limit of 0.5 EU/mL, using an E. coli O111:B4 standard over a 0.01 to 1.0 EU/mL detection range. Positive and negative controls both behaved as expected. Final determination, pass.
- Rapid sterility screen on the same date: no aerobic or anaerobic bacterial growth, no fungi or yeast detected, over a two-day incubation at 30 to 35 degrees Celsius.
- Elemental impurities by ICP-MS: lead, arsenic, cadmium and mercury all below their stated limits, with spike recoveries between 91% and 102% against a 70% to 150% criterion.
- Net content measured at 11.23 mg in a vial labelled 10 mg.
The endotoxin and sterility lines are the ones that matter here, because they are the only part of FDA's stated concern that a buyer can actually verify from outside. Whether they appear at all is a batch question rather than a product question. This vendor's February 2026 certificates carry neither test, on Semax and on the neighbouring Selank alike, and both compounds gained them on their June batches, which we went through on the Selank buying page and the row its February certificate leaves blank. So read every certificate on the product page rather than only the one that is a clickable link.
The rows where it is weaker, because there are some
Three things stop this from being a clean sweep, and a page that pretended otherwise would not be worth reading.
First, the sterility result is a rapid screen rather than a compendial test, and the document says so itself: it describes the method as suitable for quality control and notes that full USP Chapter 71 sterility testing may be required for regulatory compliance [4]. Credit the vendor for printing that caveat. Read it as what it is.
Second, the listing copy describes "neuroprotective and cognitive-enhancing properties" in research models. The research-use-only statement is there too, but that is claim-adjacent language on a product with no approved indication, and on the criteria above it costs a point.
Third, every one of these results describes one batch. A clean endotoxin figure on lot 30-05260628 is a fact about lot 30-05260628 and not a promise about the vial that reaches you. Check the lot number when the package arrives, and if it does not match the published certificate, ask for the one that does.
Where the checklist leaves a realistic buyer
There is no supervised route. No US prescriber can write for Semax, because there is no approved product to prescribe, and no compounding pharmacy can legitimately prepare it, because it appears on no current category list. That is a different situation from some compounds this site covers, and closer to the research-vial market described in how to judge a BPC-157 supplier for yourself.
If you want the reasoning behind the endotoxin question rather than the conclusion, we worked through it at length on the NAD+ side, where FDA published a direct warning about injectable preparations, and the sterility argument on the NAD+ injection page is the fuller version. If you would rather see the criteria turned into an explicit scoring scale, that is the ranking method on our best Semax source page.
Questions readers ask before ordering
- Is Semax approved or legal to buy in the United States?
- There is no FDA-approved Semax product for any indication. It is sold in the United States as a research chemical, which is a lawful category for sale and possession but explicitly not for human use. Its Russian registration is a different regulator applying a different standard and does not carry over.
- Is Semax on the FDA Category 2 list?
- No. Semax was nominated for the 503A bulks list and was placed in category 2 under the interim policies, then the nomination was withdrawn by the nominator. It appears on no current category list. Pages saying it is category 2 today are citing a snapshot that has moved.
- What does this certificate actually prove?
- On batch 30-05260628, that the powder is 99.886% pure against a greater-than-98% specification, that it is the right molecule by LC-MS, that endotoxin came in below 0.20 EU/mL against a 0.5 EU/mL limit, that a two-day sterility screen found no growth, and that four heavy metals were under their limits. It proves nothing about human safety, which is the thing FDA says nobody has the data for.
- Why does endotoxin keep coming up on this page?
- Because it is the specific thing FDA flagged, in the form of immunogenicity risk from aggregation and peptide-related impurities, and because a purity assay cannot see it. Endotoxins are bacterial cell wall fragments that survive sterilisation and require their own test.
- Is Semax related to the GLP-1 medication I am already taking?
- No. It has no incretin activity, no effect on gastric emptying and no weight-management indication anywhere. Nothing on this page should be read as a reason to add it to a GLP-1 regimen.
- Does the nasal spray format change the answer?
- It changes what sterility means for the product rather than the regulatory position. Ascension sells a lyophilised vial and not a spray. The consumer spray sellers are a separate market with generally thinner documentation, and none of it is FDA approved either.
Semax where to buy comes down to which seller will show you its work. Most of this market sells a percentage on a landing page. One certificate in it runs the test FDA actually named, publishes the acceptance limit next to the result, and prints its own caveat about the sterility method. That is not a safety guarantee and it should not be sold to you as one. It is simply more than anyone else is showing, and you can confirm every line of it yourself before you spend anything.
References
- FDA, Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks, content current as of 04/22/2026
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, category lists updated May 14, 2026
- PubChem Compound Summary for CID 9811102, Semax, National Library of Medicine
- Kovera Labs, Certificate of Analysis, Semax 10 mg, batch 30-05260628, report KVR-2026-E848E0, certified 06/15/2026
- FDA, Pyrogen and Endotoxins Testing: Questions and Answers, guidance for industry